Buy Divis Laboratories; target of Rs 5711: Hem Securities Dayanand Saini | December 2, 2021 | Finacial News | No Comments Hem Securities is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 5711 in its research report dated November 30, 2021. Related Posts Buy Bandhan Bank; target of Rs 500: Emkay Global Financial No Comments | Apr 15, 2021 Hold Godrej Consumer Products; target of Rs 1030: Emkay Global Financial No Comments | Sep 29, 2021 Buy Gujarat Gas target of Rs 666: Prabhudas Lilladher No Comments | Jun 3, 2021 Buy Jindal Steel and Power; target of Rs 478: Motilal Oswal No Comments | Dec 8, 2021 About The Author Dayanand Saini